首页> 美国卫生研究院文献>Bio-protocol >Mouse Renal Artery Catheterization for Local Delivery of Drugs in Capsulated or Free Forms
【2h】

Mouse Renal Artery Catheterization for Local Delivery of Drugs in Capsulated or Free Forms

机译:小鼠肾动脉导管插入术用于胶囊或游离形式的药物局部递送

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Arterial delivery to the kidney offers significant potential for targeted accumulation and retention of cells, genetic material, and drugs, both in free and encapsulated forms, because the entire dose passes through the vessels feeding this organ during the first circulation of blood. At the same time, a detailed study on the safety and effectiveness of developed therapies in a large number of experimental animals is required. Small laboratory animals, especially mice, are the most sought-after in experimental and preclinical testing due to their cost-effectiveness. Most of the described manipulations in mice involve puncturing the walls of the abdominal aorta or renal artery for direct administration of solutions and suspensions. Such manipulations are temporary and, in some cases, result in long-term occlusion of the aorta. Ultimately, this can lead to disruption of blood flow as well as functional and morphological changes to the kidneys. In addition, few of these protocols describe targeted delivery to the kidney. The presented protocol involves the injection of test substances or suspensions through the renal artery into one of the kidneys. The catheter is implanted into the femoral artery and then advanced into the abdominal aorta and renal artery within the vessels. In this case, the integrity violation of the renal artery or abdominal aorta is absent. Occlusion of the renal artery is necessary only immediately at the time of injection to minimize the entry of the injected substance into the aorta. This protocol is similar to the clinical procedure for delivering a catheter into the renal artery and is designed for real-world operating conditions. Key features • The protocol involves implantation of a catheter into the vascular system through a puncture of the femoral artery, similar to the clinical procedure.• The catheter is moved inside the vessels without puncture or ligation to the aorta or renal artery.• The protocol involves only a short-term block of the blood supply to the target kidney (the time required for direct administration of the drug).• Suitable for chronic experiments on mice, since the catheter is removed from the vascular system immediately after drug administration.
机译:动脉输送到肾脏为细胞、遗传物质和药物的靶向积累和保留提供了巨大的潜力,包括游离和包封形式,因为在血液的第一次循环期间,整个剂量都通过为该器官供血的血管。同时,需要对已开发疗法在大量实验动物中的安全性和有效性进行详细研究。小型实验动物,尤其是小鼠,由于其成本效益,在实验和临床前测试中最受追捧。大多数描述的小鼠操作涉及刺穿腹主动脉或肾动脉壁以直接施用溶液和悬浮液。这种操作是暂时的,在某些情况下会导致主动脉长期闭塞。最终,这可能导致血流中断以及肾脏的功能和形态变化。此外,这些方案中很少有描述靶向递送到肾脏的。提出的方案涉及通过肾动脉将测试物质或悬浮液注射到其中一个肾脏中。导管植入股动脉,然后推进到血管内的腹主动脉和肾动脉。在这种情况下,不存在肾动脉或腹主动脉的完整性侵犯。仅在注射时立即需要阻塞肾动脉,以尽量减少注射物质进入主动脉。该方案类似于将导管输送到肾动脉的临床程序,专为实际操作条件而设计。主要特点• 该方案涉及通过股动脉穿刺将导管植入血管系统,类似于临床程序。• 导管在血管内移动,无需穿刺或结扎到主动脉或肾动脉。• 该方案仅涉及短期阻断目标肾脏的血液供应(直接给药所需的时间)。• 适用于小鼠的慢性实验, 因为导管在给药后立即从血管系统中取出。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号